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Abstract 
Background: It is important to evaluate change in order to re-assure commissioners, staff and 
patients of the effectiveness of interventions, but also in order to identify areas for 
improvement. Objective: To consider whether analysis of improvement at the level of the 
individual, taking into account measurement error, may offer a further valuable way to assess 
change and inform service development over considering change at the group level in a post-
acute neuro-rehabilitation unit.  Method: Pre and post intervention Scores on the FIM+FAM 
Full Scale and Cognitive and Motor subscales were considered for eighteen patients aged 
between 35 and 81 with mixed diagnoses who attended a post-acute inpatient neuro-
rehabilitation unit for treatment. Results: Statistically significant improvements were 
achieved on the FIM+FAM Full Scale and Cognitive and Motor subscales in a whole group 
analysis. Reliable change analyses for each patient within each subscale however identified 
only half of the sample achieved reliable improvement within the Motor domain and just one 
person within the Cognitive domain (5.6%). Conclusions: Findings are consistent with the 
emphasis of the rehabilitation unit on physical/motor function, and unsurprising as many of 
those assessed had multiple sclerosis, an often deteriorative condition. Use of reliable change 
analysis allowed a more detailed understanding of intervention impact, potentially identifying 
what services reliably work for whom, thereby informing future planning. 
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Introduction 
Inpatient neurological rehabilitation offers a coordinated multidisciplinary (MD) 
approach to treating a wide range of neurological conditions.  The aim of treatment is to 
maximise potential for physical, cognitive, social and psychological functioning to enhance 
people’s ability to participate in society and their quality of life (Turner-Stokes, 2010).  This 
fits with the aims of the National Service Framework (Department of Health, 2005) which 
emphasises the need to support people with long-term neurological conditions to achieve the 
greatest possible level of independence and social inclusion.  
There has been a recent shift in health services away from process targets and onto 
measuring clinically relevant outcomes (Department of Health, 2010). Measuring clinical 
outcomes within rehabilitation programmes provides a means of determining the “extent to 
which the interventions have achieved their aims” (Royal College of Physicians & British 
Society of Rehabilitation Medicine, 2003 p. 22). This provides valuable information for 
commissioners, staff and patients, which can also be used to guide service development and 
drive up the standards of care being delivered (Department of Health, 2008).  
Despite some of the inherent challenges associated with evaluating a vastly 
heterogeneous patient group presenting with a diffuse and diverse range of deficits, there is 
an emerging evidence base which suggests that neurological rehabilitation is an effective 
intervention for patients diagnosed with a range of neurological impairments. These include 
acquired brain injury (ABI), Traumatic Brain Injury (TBI), stroke, multiple sclerosis (MS), 
spinal cord injuries, neuromuscular conditions and other brain pathology (Prvu Bettger, & 
Stineman, 2007; Department of Health, 2005; Freeman, Hobart, Playford, Undy & 
Thompson, 2005; Turner-Stokes, 2008).  Studies investigating the differential effects of early 
versus delayed admission in TBI, stroke, and ABI populations have found that early post-
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acute rehabilitation is associated with better outcomes and reduced length of stay (Ashley, 
O’Shanick, & Kreber, 2009; Salter, Jutai, Hartley, Foley, Bhogal et al. 2006; Turner-Stokes, 
2008).  
In rehabilitations centres in the UK, functional outcome measures tend to be the most 
widely used measure of change (Skinner & Turner-Stokes, 2006). Typically within this field, 
change is measured at the group level. Whilst this clearly has its merits, relying solely on 
aggregate data analysis can be at the cost of valuable information regarding individual 
responses to treatment which might more fully inform practitioners and guide treatment 
planning and clinical practice.  Reliable change methods were first popularised by Jacobson 
and Truax (1991) as means of determining the reliability of change within psychotherapy 
research, that is, change that is greater than would be expect than simply due to measurement 
error. Reliable change analysis was a novel approach as it provided a means of determining 
whether the magnitude of change for a given client was reliable. To date, while reliable 
change analysis has been utilised in neuro recovery/rehabilitation contexts such as to 
document outcomes post unruptured intracranial aneurysm (Towgood, Ogden & Mee, 2005), 
or cognitive changes following anterior temporal lobectomy (Dulay, Levin, York, Li, Mizrahi 
et al. (2009) and bilateral subthalamic nucleus deep brain stimulation (York, Dulay, Macias, 
Levin, Grossman et al. 2008) and in specific intervention research (e.g., Freedburg, Lynch III, 
& Ryan, 2011; Jenkins et al., 2006; Kesler, Sheau, Koovakkattu & Reiss, 2011), its potential 
usefulness in routine multi-disciplinary service evaluation has not been documented. It was 
expected that an evaluation of a neurorehabilitation service using reliable change analysis 
would provide additional information over and above that provided via traditional group 
analysis. 
 
 
6 
 
 
Method 
 
Service setting 
The ward evaluated was based in a community hospital offering services primarily to 
working age adults (18 - 65) who had experienced an acute neurological event such as stroke 
and people who had experienced changes in existing neurological conditions. Older adults (> 
65) were accepted if they were considered able to participate and benefit from the intensive 
rehabilitation offered. 
 
Sample 
In total, 22 patients were admitted to the unit over a 6 month period. All patients for whom 
complete data were available were included in the study (n = 18, 81.8%). Patient’s 
ages ranged between 35 and 81, with a mean age of 57.7 (SD 11.77) years. Age data was 
missing for one patient. The sample was comprised of 11 males (61%) and 7 females (39%). 
The length of admission ranged from 17 to 131 days with a mean of 45.28 days. The most 
common reason for admission was multiple sclerosis (n = 7, 38.9%) followed by stroke (n = 
2, 11.1%). Other reasons for admission included myalgic encephalopathy, brain tumour, 
Cavernous hemangioma, Parkinson’s disease, spinal cord infarct, spinal muscular atrophy, 
cervical myelopathy, cerebellar ataxia and subacromial decompression (all n = 1, 5.6%). 
 
Measures 
The FIM+FAM is comprised of the Functional Independence Measure (FIM): an 18 item 
scale of global disability and the Functional Assessment Measure (FAM) which adds twelve 
items which specifically address cognitive and psychosocial function (Hamilton, Granger, 
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Sherwin, Sielenzny, & Tashman, 1987; Turner-Stokes, Nyein, Turner-Stokes & Gatehouse, 
1999). The FIM+FAM is widely used in routine clinical practice in rehabilitation centres 
across the UK (Skinner & Turner-Stokes, 2006). Function is assessed by clinicians based on 
direct observations and scoring is undertaken by a multidisciplinary team. Ratings are made 
on a 7 point scale ranging from 1 (total assistance) to 7 (complete independence). Ratings are 
made at admission within 10 working days and during the final week before discharge. Factor 
analysis has identified that items fall within two subscales which reflect cognitive and motor 
domains (Turner-Stokes & Seigert, 2013). The FIM+FAM has been found to be a valid and 
reliable measurement of neurologic disability  though with some variability in the 
responsiveness to change across items (Hobart et al., 2001) ; the motor scale appears to 
demonstrate greater responsiveness to change than the cognitive scale. Reliability ratings for 
cognitive items have also been found to be lower than motor items which may be attributable 
to the abstract nature of items (Alcott, Dixon & Swann, 1997). Findings from a study 
(Hawley, Taylor, Hellawell & Pentland, 1999) into the psychometric properties of the FIM + 
FAM justify treating the “raw scores as good and useful approximations to points on interval 
scales of measurement and treating them arithmetically to characterise levels of functioning 
on the subscales” (Hawley et al., p. 754 ) though it is acknowledged homogeneity of a sample 
may be an issue in this. 
 
Planned Analysis 
This was a retrospective data analysis evaluation of functional change scores between 
admission and discharge for patients accessing the unit over a twelve month period. 
Wilcoxon signed ranks tests were used to compare pre- and post-intervention scores for the 
motor and cognitive subscales as identified by Turner-Stokes and Siegert’s (2013) factor 
analysis of the FIM+FAM. 
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Reliable change was calculated for each participant using the Leeds Reliable Change Index 
Calculator (Agostinis, Morley and Dowzer, 2008) which adheres to the method described by 
Jacobson and Truax (1991). This method involves subtracting the post treatment score from 
the pre-treatment score and dividing this by the standard error of the difference. The standard 
error of the difference describes the spread of distribution of change scores that would be 
expected if no actual change had occurred. In accordance with this method, reliable change 
index (RCI) scores of 1.96 or above were considered reliable (p < .05). Cronbach’s apha (α) 
scores provided by Turner-Stokes and Siegert (2013) for the cognitive and motor subscale 
were used as parameters of the reliability of the measure. 
 
Group change 
 
Table 1 shows the medians and inter-quartile ranges for the full scale and subscale scores on 
the FIM+FAM measure at admission and at discharge. There were significant improvements 
at the group level on the full scale score (Z(17) = -.3291, p < .001, r = 0.65) and on the 
cognitive (Z(17) = -2.873, p = .002, r =.048) and motor subscales (Z(17) = -3.297, p <.001, r 
= 0.55). 
 
Insert Table 1 about here 
 
Reliable Change 
Reliable change calculations were conducted for each patient for the motor and cognitive 
subscales. As can be seen in Table 2 with respect to the motor subscale, nine of the eighteen 
patients (50%) showed reliable improvement, as indicated by a change of 13.44 points or 
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more and nine patients showed no reliable change (50%). With respect to the cognitive 
subscale, one patient (5.6%) demonstrated reliable improvement, one patient (5.6%) reliable 
deterioration (RCI reference score   > 13.53), with 16 patients (88.8%) failing to demonstrate 
reliable change (Table 3).  
Insert Table 2 and 3 about here 
 
Discussion 
This evaluation investigated whether changes occurred within functional domains following 
multidisciplinary treatment in a neurological rehabilitation unit. The findings demonstrated 
significant improvements at the group level in full scale scores at discharge as well as the 
cognitive and motor subscales. This improvement is generally consistent with the literature 
suggesting the efficacy of multi-disciplinary rehabilitation for patients with a range of 
neurological disorders and with the findings from a previous evaluation of the unit (Guerrier 
& Kneebone, 2004). Given that a large proportion (38.9%) of the sample had a diagnosis of 
MS, which is typically a deteriorative condition, these findings are impressive. A recent 
meta-analysis of cognitive rehabilitation in MS found that whilst there was some evidence of 
improvement following intervention when studies were evaluated individually, cumulatively 
the evidence for cognitive improvement was low (Rosti-Otajarvi & Hamalianen, 2011). This 
may be reflected in the discrepancy found between the degree of improvement on the motor 
and cognitive subscales.  However, as we have demonstrated, significant group-level 
improvements are not necessarily indicative of reliable improvement at the individual level. 
Whilst the group results indicate improvement at the group level in terms of increased 
independence, analyses of individual patient data suggests that only half of the sample (50%) 
included in the evaluation demonstrated reliable improvements in scores within the motor 
domain and only one patient within the cognitive domain (5.6%). Within the cognitive 
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domain, one patient (5.6%) demonstrated reliable deterioration. This is likely to reflect the 
emphasis of the unit at that time which was more focussed on physical goals and which 
would have influenced the nature of referrals received. Indeed, the unit has a sister service 
that prioritises cognitive rehabilitation and is the local head injury in-patient rehabilitation 
service. To some degree, this may also reflect factors associated with the FIM+FAM such as 
greater responsiveness to change across motor scale items or reliability issues due to the 
abstract nature of cognitive items (Alcott, Dixon & Swann, 1997). 
As demonstrated by this study, the inclusion of reliable change methods provides 
another dimension to our analysis of the data gathered at the unit which has clear clinical 
relevance. Individual data analyses using this method demonstrated that whilst there was 
overall significant improvement following neurological rehabilitation in the setting evaluated, 
improvements were only reliable for half the patients in the motor areas of functioning and 
for only one patient in the cognitive domain. Clinically, this information is useful as it 
enables practitioners to gain insights regarding individual patient’s responsiveness to 
treatment and provides a benchmark from which to assess the magnitude of change being 
observed. This information can be assimilated with other clinically relevant information in 
order to form a more comprehensive understanding of patients’ progression through 
treatment. This enables practitioners to take a more person centred approach to treatment 
planning as well as providing information which can inform evaluation of patient centred 
goals. At a service level, this information not only provides commissioners with information 
regarding the effectiveness of interventions but also can help provide a more comprehensive 
picture regarding service provision. For example findings within this study reflected the 
emphasis within the unit on physical / motor functioning. In response to this, the service may 
want to consider ways of improving rates of cognitive functioning following treatment. 
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Alternatively, this may highlight issues associated with the relevance or adequacy of 
measures currently being used to capture clinical outcomes.  
 
Limitations  
There are various factors associated with the nature of neurorehabilitation research that make 
interpretations difficult. These include lack of control group, the vastly heterogeneous nature 
of the patient group, variations in the clinical manifestations of symptoms associated with 
neurological disorders or injury and difficulties accounting for factors such as spontaneous 
recovery.  
In this particular study the lack of data regarding disease course for individual patients or 
duration between the acute and post acute phases of brain injury limits interpretations. This 
information is relevant given that the evidence suggests that early admission is associated 
with better outcomes (Ashley et al., 2009; Salter et al. 2006; Turner-Stokes, 2008). The 
relevance of data on disease course is particularly relevant to diagnoses such as MS where 
there are progressive and relapse remitting phases which will impact on functional ability.   
Another limitation of the study is that outcome is measured solely in terms of clinician rated 
changes in functional outcome. This does not necessarily reflect the idiographic patient 
centred goals encompassing patient’s views, cultural background and pre-morbid lifestyle 
that should be a key feature of rehabilitation (Royal College of Physician & British Society of 
Rehabilitation Medicine, 2003). Accordingly, standardised measures of functional outcome 
may not always be the most appropriate means of assessing meaningful change within this 
population, particularly when used alone. Similarly, reliable change analysis may not always 
be the most appropriate method for assessing the meaningful nature of changes in that it does 
not allow these factors to be accounted for.  
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A drawback of the FIM + FAM is that although it is designed for use in those who have 
suffered a brain-injury, this population is heterogeneous which notoriously adds 
complications when trying to interpret variations on the group level. The range of disability 
and need for assistance varies widely across the patient population and so the relative 
difficulties on a single item, such as bathing, will differ from patient to patient but this is not 
reflected in the scale.  
The RCI aims to demonstrate clinical change beyond measurement error in such a way that 
an observed difference of a specific magnitude implies the same degree of clinical change 
regardless of the starting point of that patient.  This clearly requires the summed raw scores to 
be equal-interval. However, it is likely that those with lower scores will have more complex 
medical conditions than those with higher scores and so for these patients the difference 
between a 1 (total assistance) and a 2 (maximal assistance) could potentially reflect a higher 
change in need than the difference between a 6 (modified independence) and a 7 (complete 
independence). Although we cannot demonstrate to what extent our current data fits the 
equal-interval description, there has been justification in treating the FIM+FAM scores in this 
way (Hawley et al., 1999) though admittedly on the basis of findings with a population 
potentially more homogeneous than that considered in this study.  Meanwhile other 
investigators have argued that total scores for scales made up of many likert items can behave 
as interval scales (Carifio & Perla, 2008). The debate is ongoing (Perdices, 2004), more 
research is needed to externally validate reliable change in the raw FIM+FAM scores. 
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Table 1  
Median and (Inter-Quartile Range) FIM+FAM scores on admission  
and discharge.  
__________________________________________________________________________ _____________________________________ 
 
 
  Admission          Discharge  
__________________________________________________________________________  
 
Full scale   171.5 (60.25)   195.0 (55.25)***  
Cognitive    83.5 (17.75)       87.0 (16.50)**  
Motor      94.0 (53.25)   108.0 (37.50)*** 
_________________________________________________________________________  
Note. *p < .05., **p < .01., ***p < .001.  
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Table 2 
Calculations for reliable change on the FIM+FAM Motor subscale.  
Participant  Admission  
length 
(days) 
Reason for referral  Pre-
treatment  
score  
Post-
treatment  
score  
Difference  Reliable  
change 
met 
  
1 91 Subacromial 
decompression 
42 77 -35 yes  
2 42 Chronic fatigue – 
Myalgic 
Encephalomyelitis 
104 104     0 no  
3 25 Multiple Sclerosis 108 108     0 no  
4 29 Multiple Sclerosis 94 110  -16 yes  
5 21 Stroke Haemorrhage  65 66   -1 no  
6 35 Cerebella ataxia 95 122 -27 yes  
7 133 Oligodendroma 
(grade 2) 
32 34   -2 no  
8 26 Spinal cord infarct 74 108 -34 yes  
9 63 Multiple Sclerosis 40 66 -26 yes  
10 76 Multiple Sclerosis 55 89 -34 yes  
11 23 Multiple Sclerosis 118 121   -3 no  
12 23 Spinal muscular 
atrophy 
72 110 -38 yes  
13 87 Stroke Haemorrhage  31 31    0 no  
14 17 Cervical myelopathy 111 111    0 no  
15 18 Parkinson 120 124   -4 no  
16 27 Cavernous 
haemangioma 
94 111 -17 yes  
17 38 Multiple Sclerosis 98 114 -16 yes 
18 41 Multiple Sclerosis 95 105 -10 no 
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Table 3  
Calculations for reliable change on the FIM+FAM Cognitive subscale.  
Participant  Admission  
length 
(days)  
Reason for 
referral  
 Pre-
treatment 
 score  
Post-
treatment  
score  
Difference  Reliable  
change 
met 
  
1 91 Subacromial 
decompression 
 76 80    -4 no  
2 42 Chronic fatigue – 
Myalgic 
Encephalomyelitis 
 81 84    -3 no  
3 25 Multiple Sclerosis  87 88    -1 no  
4 29 Multiple Sclerosis  83 86    -3 no  
5 21 Stroke 
Haemorrhage  
 69 72    -3 no  
6 35 Cerebella ataxia  74 88  -14 yes  
7 133 Oligodendroma 
(grade 2) 
 87 74   13 no  
8 26 Spinal cord infarct  92 95    -3 no  
9 63 Multiple Sclerosis  33 41    -8 no 
10 76 Multiple Sclerosis  75 79    -4 no  
11 23 Multiple Sclerosis  93 95    -2 no  
12 23 Spinal muscular 
atrophy 
 95 97    -2 no  
13 87 Stroke 
haemorrhage  
 25 26    -1 no  
14 17 Cervical 
myelopathy 
 94 94     0 no  
15 18 Parkinson  93 94    -1 no  
16 27 Cavernous 
haemangioma 
 80 81    -1 no  
17 38 Multiple Sclerosis  84 95  -11 no  
18 41 Multiple Sclerosis  84 89    -5 no  
 
 
